Section 6 of 6
References
120 sources
- Alshekhlee et al. (2009) (opens in a new tab)
- ANZCTR ACTRN12622001265763 (opens in a new tab)
- ANZCTR ACTRN12624000352505 (opens in a new tab)
- Barnett-Tapia et al. (2026) (opens in a new tab)
- Beydoun et al. (2026) (opens in a new tab)
- Bkemv prescribing information (2026) (opens in a new tab)
- Bruckman et al. (2024) (opens in a new tab)
- Carr et al. (2010) (opens in a new tab)
- Cavalcante et al. (2024) (opens in a new tab)
- Choi et al. (2025) (opens in a new tab)
- Çipi et al. (2026) (opens in a new tab)
- Claytor et al. (2023) (opens in a new tab)
- ClinicalTrials.gov NCT06282159 (opens in a new tab)
- ClinicalTrials.gov NCT06858579 (opens in a new tab)
- ClinicalTrials.gov NCT07647510 (opens in a new tab)
- Dewilde et al. (2023a) (opens in a new tab)
- Dewilde et al. (2023b) (opens in a new tab)
- Dewilde et al. (2025a) (opens in a new tab)
- Dewilde et al. (2025b) (opens in a new tab)
- Dianthus Therapeutics (2022) (opens in a new tab)
- Dianthus Therapeutics (2023) (opens in a new tab)
- Dianthus Therapeutics (2024a) (opens in a new tab)
- Dianthus Therapeutics (2025b) (opens in a new tab)
- Dianthus Therapeutics (2025c) (opens in a new tab)
- Dianthus Therapeutics (2026c) (opens in a new tab)
- Dianthus Therapeutics (2026d) (opens in a new tab)
- Dianthus Therapeutics (2026g) (opens in a new tab)
- Dianthus Therapeutics Form 10-K (2025) (opens in a new tab)
- Dianthus Therapeutics Form 10-K (2026) (opens in a new tab)
- Dianthus Therapeutics Form 10-Q (2026c) (opens in a new tab)
- Dianthus Therapeutics Form 8-K (2026) (opens in a new tab)
- Dianthus Therapeutics presentation (2024a) (opens in a new tab)
- Dianthus Therapeutics presentation (2024b) (opens in a new tab)
- Dianthus Therapeutics presentation (2025a) (opens in a new tab)
- Dianthus Therapeutics presentation (2025b) (opens in a new tab)
- Dianthus Therapeutics presentation (2026a) (opens in a new tab)
- Dianthus Therapeutics presentation (2026c) (opens in a new tab)
- Dianthus Therapeutics presentation (2026e) (opens in a new tab)
- Dimachkie et al. (2026) (opens in a new tab)
- Dodd et al. (2025) (opens in a new tab)
- Dresser et al. (2021) (opens in a new tab)
- Epysqli prescribing information (2026) (opens in a new tab)
- EU Clinical Trials Information System 2026-525298-38-00 (opens in a new tab)
- Gelinas et al. (2022) (opens in a new tab)
- Gilhus et al. (2019) (opens in a new tab)
- Gilhus et al. (2024) (opens in a new tab)
- Gilhus et al. (2026) (opens in a new tab)
- Gokhale et al. (2024) (opens in a new tab)
- Grob et al. (2008) (opens in a new tab)
- Gronseth et al. (2020) (opens in a new tab)
- Grover et al. (2026a) (opens in a new tab)
- Grover et al. (2026b) (opens in a new tab)
- Habib et al. (2024) (opens in a new tab)
- Hehir and Silvestri (2018) (opens in a new tab)
- Herr et al. (2023) (opens in a new tab)
- Howard (2018) (opens in a new tab)
- Huang et al. (2024) (opens in a new tab)
- Hughes et al. (2023) (opens in a new tab)
- ICER (2021) (opens in a new tab)
- Imaavy prescribing information (2026) (opens in a new tab)
- Jackson et al. (2023) (opens in a new tab)
- Jackson et al. (2025) (opens in a new tab)
- Jacob et al. (2025) (opens in a new tab)
- Jaretzki et al. (2000) (opens in a new tab)
- Jiang et al. (2025) (opens in a new tab)
- Jul Jarbæk Nielsen et al. (2025) (opens in a new tab)
- Kaminski et al. (2024) (opens in a new tab)
- Khateb et al. (2025) (opens in a new tab)
- Kusner et al. (2012) (opens in a new tab)
- Landfeldt et al. (2020) (opens in a new tab)
- Li et al. (2026) (opens in a new tab)
- Lien et al. (2024) (opens in a new tab)
- Lord et al. (2026) (opens in a new tab)
- Manolopoulos et al. (2025) (opens in a new tab)
- Meisel et al. (2026) (opens in a new tab)
- Mestinon prescribing information (2023) (opens in a new tab)
- Muppidi et al. (2011) (opens in a new tab)
- Muppidi et al. (2022) (opens in a new tab)
- Myasthenia Gravis Foundation of America (opens in a new tab)
- Narayanaswami et al. (2021) (opens in a new tab)
- Narayanaswami et al. (2026) (opens in a new tab)
- Parthan et al. (2024) (opens in a new tab)
- Peric et al. (2026b) (opens in a new tab)
- Peric et al. (2026c) (opens in a new tab)
- Peric et al. (2026e) (opens in a new tab)
- Pesa et al. (2026a) (opens in a new tab)
- Pesa et al. (2026b) (opens in a new tab)
- Phillips et al. (2022) (opens in a new tab)
- Rodrigues et al. (2024) (opens in a new tab)
- Rousseff (2021) (opens in a new tab)
- Rystiggo prescribing information (2025) (opens in a new tab)
- Salari et al. (2021) (opens in a new tab)
- Sanders et al. (2016) (opens in a new tab)
- Sciancalepore et al. (2025) (opens in a new tab)
- Shelly et al. (2026) (opens in a new tab)
- Siddiqi et al. (2025) (opens in a new tab)
- Silvestri et al. (2026) (opens in a new tab)
- Smith et al. (2026) (opens in a new tab)
- Soliris prescribing information (2026) (opens in a new tab)
- Suzuki et al. (2026) (opens in a new tab)
- Tice et al. (2022) (opens in a new tab)
- Ultomiris prescribing information (2026) (opens in a new tab)
- Uplizna prescribing information (2025) (opens in a new tab)
- Vinciguerra et al. (2023) (opens in a new tab)
- Vissing et al. (2020) (opens in a new tab)
- Vissing et al. (2024) (opens in a new tab)
- Vu et al. (2026a) (opens in a new tab)
- Vu et al. (2026b) (opens in a new tab)
- Vyvgart Hytrulo prescribing information (2026) (opens in a new tab)
- Vyvgart prescribing information (2026) (opens in a new tab)
- WHO Collaborating Centre for Drug Statistics Methodology ATC/DDD Index (2026) (opens in a new tab)
- WHO Drug Information Recommended INN List 94 (2025) (opens in a new tab)
- WHO INN monoclonal antibody nomenclature scheme (2022) (opens in a new tab)
- WHO Proposed INN List 132 (2024) (opens in a new tab)
- Wolfe et al. (2016) (opens in a new tab)
- Wolfe et al. (2019) (opens in a new tab)
- Ye et al. (2024) (opens in a new tab)
- Yoder et al. (2025) (opens in a new tab)
- Zhdanava et al. (2024) (opens in a new tab)
- Zilbrysq prescribing information (2026) (opens in a new tab)